Filing Overview
Hims & Hers Health, Inc. filed a Form 8-K reporting a board appointment effective March 30, 2024. The filing does not report quarterly or annual financial results.
Business Context and Reporting Period
The company increased its board from nine to ten directors and appointed Christopher Payne, age 55, to the newly created vacancy. He will serve until the 2024 annual meeting of stockholders and until his successor is elected and qualified, unless his service ends earlier.
Financial and Capital Metrics
- The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating metrics.
- No financial statements or financial guidance are included.
Material Changes and Governance Matters
- The board determined that Mr. Payne meets the independence requirements of the New York Stock Exchange and the Securities Exchange Act.
- Mr. Payne had not been appointed to any board committee as of the filing.
- His initial restricted stock unit award will be valued at $400,000 under the company’s director compensation program.
- Mr. Payne also entered into the company’s standard indemnification agreement.
- The filing states that there are no election-related arrangements or understandings, no relevant family relationships, and no reportable related-party transactions under Item 404(a) of Regulation S-K.
Outlook, Risks, and Unusual Items
The filing provides no management outlook, business guidance, risk-factor update, contingency disclosure, or unusual operating item. The principal disclosed item is the appointment and compensation of the new independent director.
Investor Verification Points
- Verify Christopher Payne’s background, independence status, and any subsequent committee assignments.
- Review the company’s 2024 proxy statement and subsequent filings for the final terms and vesting of the $400,000 restricted stock unit award.
- Check later filings for changes to the board’s composition or Mr. Payne’s service before the 2024 annual meeting.
- Consult the company’s periodic financial filings for revenue, profitability, cash flow, debt, liquidity, and guidance information not included in this Form 8-K.